These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 11420398)
1. Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc(+) allele. Andreassen A ; Vikse R; Steffensen IL; Paulsen JE; Alexander J Mutagenesis; 2001 Jul; 16(4):309-15. PubMed ID: 11420398 [TBL] [Abstract][Full Text] [Related]
2. One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene. Andreassen A; Møllersen L; Vikse R; Steffensen IL; Mikalsen A; Paulsen JE; Alexander J Mutat Res; 2002 May; 517(1-2):157-66. PubMed ID: 12034317 [TBL] [Abstract][Full Text] [Related]
7. Age at exposure and Apc status influence the levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in mouse intestine and liver. Steffensen IL; Schut HA; Alexander J Mutat Res; 2005 Nov; 587(1-2):73-89. PubMed ID: 16202642 [TBL] [Abstract][Full Text] [Related]
8. Impact of genetic background on spontaneous or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumorigenesis in Min/+ mice. Steffensen IL; Alexander J Cancer Lett; 2006 Aug; 240(2):289-96. PubMed ID: 16343741 [TBL] [Abstract][Full Text] [Related]
9. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice. Steffensen IL; Paulsen JE; Eide TJ; Alexander J Carcinogenesis; 1997 May; 18(5):1049-54. PubMed ID: 9163695 [TBL] [Abstract][Full Text] [Related]
10. Incorporation of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) into fur and correlation with intestinal tumourigenesis in Min/+ mice. Steffensen IL; Janak K; Hegstad S; Andreassen A; Paulsen JE; Reistad R; Alexander J Pharmacol Toxicol; 2003 Mar; 92(3):131-6. PubMed ID: 12753428 [TBL] [Abstract][Full Text] [Related]
11. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice. Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818 [TBL] [Abstract][Full Text] [Related]
12. Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts. Steffensen IL; Schut HA; Paulsen JE; Andreassen A; Alexander J Cancer Res; 2001 Dec; 61(24):8689-96. PubMed ID: 11751386 [TBL] [Abstract][Full Text] [Related]
13. Effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on intestinal polyp development in Apc delta 716 knockout mice. Oshima M; Oshima H; Tsutsumi M; Nishimura S; Sugimura T; Nagao M; Taketo MM Mol Carcinog; 1996 Jan; 15(1):11-7. PubMed ID: 8561861 [TBL] [Abstract][Full Text] [Related]
14. Intestinal toxicity and carcinogenic potential of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in DNA repair deficient XPA-/- mice. Klein JC; Beems RB; Zwart PE; Hamzink M; Zomer G; van Steeg H; van Kreijl CF Carcinogenesis; 2001 Apr; 22(4):619-26. PubMed ID: 11285198 [TBL] [Abstract][Full Text] [Related]
15. High potency of bioactivation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mouse colon epithelial cells with Apc(Min) mutation. Bellocq D; Molina J; Rathahao E; Canlet C; Taché S; Martin PG; Pierre F; Paris A Mutat Res; 2008 May; 653(1-2):34-43. PubMed ID: 18434241 [TBL] [Abstract][Full Text] [Related]
16. The food mutagen 2-amino-9H-pyrido[2,3-b]indole (AalphaC) but not its methylated form (MeAalphaC) increases intestinal tumorigenesis in neonatally exposed multiple intestinal neoplasia mice. Steffensen IL; Paulsen JE; Alexander J Carcinogenesis; 2002 Aug; 23(8):1373-8. PubMed ID: 12151357 [TBL] [Abstract][Full Text] [Related]
17. Obesity promotes PhIP-induced small intestinal carcinogenesis in hCYP1A-db/db mice: involvement of mutations and DNA hypermethylation of Apc. Wang H; Liu A; Kuo Y; Chi E; Yang X; Zhang L; Yang CS Carcinogenesis; 2016 Jul; 37(7):723-730. PubMed ID: 27207656 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development. Haines J; Dunford R; Moody J; Ellender M; Cox R; Silver A Genes Chromosomes Cancer; 2000 Aug; 28(4):387-94. PubMed ID: 10862047 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and nonsense mutation in Apc in azoxymethane-induced colonic tumours in min mice. Møllersen L; Paulsen JE; Alexander J Anticancer Res; 2004; 24(5A):2595-9. PubMed ID: 15517863 [TBL] [Abstract][Full Text] [Related]
20. More frequent beta-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-treated rats. Tsukamoto T; Tanaka H; Fukami H; Inoue M; Takahashi M; Wakabayashi K; Tatematsu M Jpn J Cancer Res; 2000 Aug; 91(8):792-6. PubMed ID: 10965019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]